NCT00363987
Controlled Study to Evaluate Efficacy and Safety of α-KA Tab With Low Protein Diet (LPD) in Delaying the Progress of Type 2 Diabetic Nephropathy (DN) treatment 4 completed NCT00317954
Spironolactone in Diabetic Nephropathy treatment 4 completed NCT00734253
Safety and Efficacy Study of Pyridorin in Patients With Nephropathy Due to Type 2 Diabetes No drug interventions prevention 2 completed NCT02829177
Microalbuminuria and Allopurinol in Type 1 Diabetes prevention 4 completed NCT01889277
Safety, Tolerability and Pharmacokinetic Study of MT-3995 in Subjects With Diabetic Nephropathy treatment 1 / 2 completed NCT00782847
Evaluation Study for the Programme DiaNe for People With Diabetic Nephropathy No drug interventions supportive_care 3 completed NCT00498147
Determining Rates of Cardiovascular Complications Among Patients of a Managed Diabetes Care Program No drug interventions Not Available Not Available unknown_status NCT00287183
6-Month Safety And Efficacy Study Of TTP488 In Patients With Type 2 Diabetes And Persistent Albuminuria No drug interventions treatment 2 completed NCT00106561
Using the Drug Spironolactone to Test If It Reduces Protein Leakage From the Kidney prevention 2 / 3 completed NCT01768611
SLC2A1 Variants and Diabetic Nephropathy No drug interventions Not Available Not Available completed NCT02409511
Microalbuminuria as a Cardiovascular Risk Factor (PRECISED Substudy) No drug interventions Not Available Not Available unknown_status NCT03436693
Efficacy and Safety of Canagliflozin (TA-7284) in Patients With Diabetic Nephropathy treatment 3 completed NCT06123871
Expression Analysis of Urinary Exosome in Type 2 Diabetic Kidney Disease and Evaluation of Its Clinical Diagnostic Value No drug interventions Not Available Not Available active_not_recruiting NCT02502071
Effect of Urinary Alkalinization on Urine Uric Acid Precipitation and Crystallization in Adults With Type 1 Diabetes treatment 4 completed NCT00340678
Renoprotection in Early Diabetic Nephropathy in Pima Indians treatment 3 completed NCT00364988
Pioglitazone and Losartan Provides Additional Renoprotection treatment Not Available completed NCT02150707
The Differential Effects of Diabetes Therapy on Inflammation Not Available Not Available completed NCT01252056
A Clinical Study to Evaluate the Efficacy and Safety of Cilostazol and Probucol in Combination on Patients With Diabetic Nephropathy treatment 4 completed NCT01858532
Study Of Diabetic Nephropathy With Atrasentan treatment 3 terminated NCT05061459
The Expression of circANKRD36 as a New Biomarker of Diabetic Nephropathy No drug interventions Not Available Not Available unknown_status NCT01273675
An Investigation on the Effect of Candesartan on Early Diabetic Nephropathy No drug interventions Not Available Not Available unknown_status NCT02410499
Efficacy and Safety of Weekly Subcutaneous MLN1202 in Improving Diabetic Nephropathy in Participants With Macroalbuminuria treatment 2 withdrawn NCT00301249
The Family Investigation of Nephropathy and Diabetes Study No drug interventions Not Available Not Available completed NCT02625649
Effect of Gastric Bypass Surgery on Diabetes Status and Microvascular Complications in Obese Type 2 Diabetic Patients No drug interventions Not Available Not Available completed NCT01003236
Evaluating the Renoprotective Effect of Milk Thistle Extract on Patients With Type II Diabetic Nephropathy treatment 2 completed NCT04981613
Study on the Efficacy and Safety of a Novel Tripterygium Wilfordii Preparation in Reducing Proteinuria in Patients With Diabetic Nephropathy No drug interventions treatment Not Available recruiting NCT00565318
Benfotiamine in Diabetic Nephropathy treatment 4 completed NCT01424319
Reducing Residual Albuminuria in Subjects With Diabetes and Nephropathy With Atrasentan treatment 2 completed NCT00171119
A Study in Patients With Diabetes Mellitus Type II of the Effect on Albuminuria of 24 Week Treatment With Valsartan, Benazepril, and Valsartan+Benazepril treatment 4 terminated NCT01331317
Effect of a Vitamin D Analogue vs Placebo on p-NT-proBNP in Patients With Type 1 DM and Diabetic Nephropathy treatment 4 completed NCT03658317
Renal Resisitive Index as an Indicator of the Progression of Diabetic Nephropathy No drug interventions diagnostic Not Available unknown_status NCT01726816
Efficacy and Safety Study of Probucol in Patients With Diabetic Nephropathy treatment 2 completed NCT02276196
Effect of LIXIsenatide on the Renal System treatment 4 completed NCT01458158
Matrix Metalloproteinases in Atherosclerosis of Chronic Kidney Disease No drug interventions Not Available Not Available unknown_status NCT01105858
Molecular and Clinical Profile of Diabetes Mellitus and Its Complications No drug interventions Not Available Not Available recruiting NCT02477163
Ayurvedic Management of Chronic Kidney Disease No drug interventions treatment Not Available completed NCT01265563
N-Acetylcysteine and Milk Thistle for Treatment of Diabetic Nephropathy treatment 2 completed NCT00067886
Matrix Metalloproteinases and Diabetic Nephropathy No drug interventions Not Available Not Available completed NCT00253786
Study for the Effectiveness of Intensive Therapy Aiming at a Remission of Diabetic Nephropathy No drug interventions treatment Not Available completed NCT04534439
Safety, Tolerability and Renal Effects of APX-115 in Subjects With Type 2 Diabetes and Nephropathy treatment 2 completed NCT00535925
Nephropathy In Type 2 Diabetes and Cardio-renal Events prevention 4 completed NCT05492630
Single and Multiple Dose Safety, Tolerability, PK and Food Effect Study of HEC73077 in Healthy Subjects No drug interventions treatment 1 completed NCT02768948
Telmisartan Promotes the Differentiation of Monocytes Into Macrophages M2 in Diabetic Nephropathy? basic_science Not Available completed NCT00044148
The Effect of LY333531 on Protein in the Urine in Patients With Type 2 Diabetes treatment 2 completed NCT02345057
A Study to Evaluate Efficacy and Safety of CS-3150 in Japanese Type 2 Diabetic Subjects With Microalbuminuria treatment 2 completed NCT01440257
A Study to Evaluate the Effect of CCX140-B on Urinary Albumin Excretion in Subjects With Type 2 Diabetes and Albuminuria treatment 2 completed NCT00171574
Antiproteinuric Effect of Valsartan and Lisinopril treatment 4 completed NCT05695573
Assessment of Urinary Uromodulin and the Corresponding Gene Expression as a Biomarker of Diabetic Nephropathy No drug interventions Not Available Not Available completed NCT00664027
Phase IIa Trial to Determine the Effects of Bardoxolone Methyl on Renal Function in Patients With Diabetic Nephropathy treatment 2 completed NCT00309127
Effects of Disease Management on Development of End Stage Renal Disease in Type 2 Diabetic Patients With Nephropathy No drug interventions treatment Not Available completed NCT00342927
Family Investigation of Nephropathy and Diabetes (F.I.N.D.) No drug interventions Not Available Not Available recruiting NCT00738660
Efficacy of Telmisartan and the Combination of Telmisartan and Ramipril in type1 Diabetes Patients With Nephropathy treatment 3 completed NCT00320060
Effect of Pyridorin in Patients With Diabetic Nephropathy No drug interventions treatment 2 completed NCT01215994
Estimation of Glomerular Filtration Rate (GFR) in Patients With Type 2 Diabetes Mellitus. No drug interventions Not Available Not Available unknown_status NCT04881994
A Study to Learn How Finerenone (BAY94-8862) Moves Into, Through and Out of the Body, How it Affects the Body, and How Safe it is in Adult Participants With Different Degrees of Reduced Liver Function and in Healthy Participants With Similar Age, Weight and Gender Distribution basic_science 1 completed NCT02035891
Low-dose Colchicine in Patients With Type 2 Diabetes Mellitus and Microalbuminuria treatment Not Available unknown_status NCT01163591
To Assess the Accuracy of the eZscan Study in the Screening for Diabetic Nephropathy No drug interventions Not Available Not Available completed NCT02065791
Evaluation of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Participants With Diabetic Nephropathy treatment 3 completed NCT02816762
CPAP Effect on Albuminuria in Patients With Diabetic Nephropathy and Obstructive Sleep Apnea No drug interventions treatment 4 completed NCT01399580
A Prospective, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate Efficacy and Safety of Atrasentan, Including Thoracic Bioimpedance, in Type 2 Diabetic Subjects With Nephropathy treatment 2 completed NCT02204280
The Significance of Urine UbA52 In the Diagnosis of Diabetic Nephropathy No drug interventions Not Available Not Available completed NCT04125329
Umbilical Cord Mesenchymal Stem Cells Therapy for Diabetic Nephropathy treatment 0 unknown_status NCT00811889
Trial to Determine the Effects of Bardoxolone Methyl on eGFR in Patients With Type 2 Diabetes and Chronic Kidney Disease treatment 2 completed NCT03407989
SWIDINEP a Swiss Diabetic Nephropathy Cohort No drug interventions Not Available Not Available unknown_status NCT06376240
The Effect of Pyridoxamine Supplementation on Microvascular Function in Type 2 Diabetes No drug interventions treatment Not Available recruiting NCT01673204
Clinical Trial Technology Development for the Validation of Surrogate Prognostic Markers in Patients With Diabetic Nephropathy screening 4 unknown_status NCT00561704
Adiponectin in Obese Women With T2DN and Effects by RAS Blocker treatment Not Available completed NCT00774904
Adiponectin and Insulin Resistance in Diabetic Nephropathy treatment Not Available completed NCT02501772
The Evaluation of Effect of Sanyinjiao (SP6) Acupressure on Early Diabetic Nephropathy No drug interventions treatment Not Available unknown_status NCT00484068
Chicken-Diet vs. Enalapril to Reduce Albuminuria treatment Not Available completed NCT01316068
Effect of Sulodexide on Albuminuria in Chinese Type 2 Diabetic Patients treatment 4 unknown_status NCT00708981
Combined Diabetes-Renal Multifactorial Intervention In Patients With Advanced Diabetic Nephropathy (ADN) No drug interventions treatment Not Available completed NCT01588795
Renal Denervation in Diabetic Nephropathy treatment 4 completed NCT02928250
Role of Carnosine as an Adjuvant Therapy for Diabetic Nephropathy in Pediatrics With Type 1 Diabetes No drug interventions treatment Not Available completed NCT00361023
Effects of Losartan on Insulin Sensitivity and Secretion in Type 2 Diabetes and Nephropathy treatment Not Available completed NCT00140543
European Trial of Immunosuppression in SPK Tx treatment 3 completed NCT02156843
Pyridorin in Diabetic Nephropathy No drug interventions treatment 3 terminated NCT02194790
Effect of Integrated CKD Care Program in Early Diabetic Nephropathy in Primary Health Care Setting. No drug interventions prevention Not Available completed NCT00920764
A Study of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System Inhibitors treatment 2 completed NCT01005121
Colchicine for Diabetic Nephropathy treatment 2 unknown_status NCT00024921
The Genetics of Kidneys in Diabetes (GoKinD) Study No drug interventions Not Available Not Available completed NCT06482021
Comparative Effectiveness Of Low Extra-Corporeal Shock Wave Versus Acetylcholine Iontophoresis On Type2 Diabetic Neuropathy No drug interventions treatment Not Available not_yet_recruiting NCT00320021
Effect of Pyridorin in Patients With Diabetic Nephropathy No drug interventions treatment 2 completed NCT02384902
Effect of Low GI/ Glycemic Load (GL) Diet in Diabetic Nephropathy Patients No drug interventions treatment Not Available completed NCT04127084
Effects of SGLT2 Inhibition Treatment on Different Levels of Albuminuria in Patients With Type 2 Diabetes treatment 4 unknown_status NCT00419484
Effect of Pioglitazone on Cardiovascular Outcome on Higashi-Saitama Trial in Patients With Type 2 Diabetes Not Available Not Available completed NCT03804879
Safety, Tolerability and Efficacy of Nidufexor in Patients With Diabetic Nephropathy treatment 2 completed NCT01028287
Adrenocorticotropic Hormone (ACTH) Treatment of Nephrotic Range Proteinuria in Diabetic Nephropathy (NRDN) treatment 4 completed NCT01843387
Safety and Efficacy of Mesenchymal Precursor Cells in Diabetic Nephropathy No drug interventions treatment 1 / 2 completed NCT00421733
The Effect of Paricalcitol Capsules on Reducing Albuminuria in Patients With Type 2 Diabetic Nephropathy Being Treated With Renin-angiotensin System Inhibitors treatment 2 completed NCT02327754
Effect of Topiroxostat on Urinary Albumin Excretion Early Stage Diabetic Nephropathy and Hyperuricemia With or Without Gout treatment 2 completed NCT06097351
Expression Analysis of Urinary Exosome in Type 2 Diabetic Nephropathy and Evaluation of Its Clinical Diagnostic Value No drug interventions Not Available Not Available active_not_recruiting NCT00141453
ORIENT: Olmesartan Reducing Incidence of End Stage Renal Disease in Diabetic Nephropathy Trial treatment 3 completed NCT04721847
Pain Neuroscience Education in Diabetic Neuropathy No drug interventions treatment Not Available completed NCT01447147
A Study to Evaluate the Safety and Efficacy of CCX140-B in Subjects With Diabetic Nephropathy treatment 2 completed NCT01923597
Effect of Green Tea (Epigallocatechin Gallate) on Albuminuria in Patients With Diabetic Nephropathy. treatment 2 completed NCT00063583
Pirfenidone: A New Drug to Treat Kidney Disease in Patients With Diabetes treatment 1 / 2 completed NCT01712061
A Phase 2 Multi-Center Study To Evaluate The Efficacy And Safety Of A Chemokine CCR2/5 Receptor Antagonist In Adults With Type 2 Diabetes And Overt Nephropathy treatment 2 completed NCT00120328
To Determine the Effects of Avosentan on Doubling of Serum Creatinine, End Stage Renal Disease and Death in Diabetic Nephropathy No drug interventions prevention 3 terminated NCT00913393
Study of FibroGen (FG)-3019 in Subjects With Type 2 Diabetes Mellitus and Kidney Disease on ACEi and/or ARB Therapy treatment 2 terminated NCT00067678
Soy Protein in Early Diabetic Nephropathy No drug interventions treatment 1 / 2 completed NCT02689778
Effect of Pirfenidone on Glomerular Filtration Rate and Albuminuria in Patients With Diabetic Nephropathy treatment 3 completed NCT03413215
Effects of Multidisciplinary Intensive Targeted Care in Improving Diabetes Outcomes: a Pilot Study in Singapore No drug interventions prevention Not Available unknown_status NCT00498537
Spironolactone for Reducing Proteinuria in Diabetic Nephropathy treatment Not Available completed NCT01015937
Effect of Turmeric on Diabetic Nephropathy treatment Not Available completed NCT00594152
Anti-Nephropathic Effects of Chronic Intermittent Intravenous Insulin Therapy (CIIIT) No drug interventions treatment 3 completed NCT02237352
Mechanisms of Diabetic Nephropathy in Ecuador No drug interventions Not Available Not Available unknown_status NCT00353600
Delaying the Progression of Diabetic Nephropathy in Pima Indians No drug interventions Not Available Not Available completed NCT00065559
Treatment of Diabetic Nephropathy treatment Not Available terminated NCT00320970
Angiotensin II Antagonism of TGF-Beta 1 treatment Not Available completed NCT00311870
Renoprotective Effect of Nisoldipine and Lisinopril in Type 1 Diabetic Nephropathy treatment 4 completed NCT01566006
Mycophenolate Mofetil, Carnitine and PDE5 Inhibitor, Three Potential Treatments for Resistant Proteinuria Slowing Diabetic Nephropathy Deterioration treatment Not Available unknown_status NCT02628106
Lipo-prostaglandin E1 Improves Renal Hypoxia Evaluated by BOLD-MRI in Patients With Diabetic Nephropathy treatment 4 completed NCT01356849
Evaluate the Efficacy and Safety of Once Daily Administration of Atrasentan Tablets (Low and High) Compared to Placebo in Reducing Residual Albuminuria in Type 2 Diabetic Patients With Nephropathy Who Are Treated With the Maximum Tolerated Labeled Dose of a Renin Angiotensin System (RAS) Inhibitor treatment 2 completed NCT00663949
Assessment of the Effect of Captopril Versus Combination of Captopril and Pentoxifylline on Reducing Proteinuria in Type 2 Diabetic Nephropathy treatment 2 / 3 completed NCT01601236
Acthar for Treatment of Proteinuria in Diabetic Nephropathy Patients treatment 2 completed NCT00557518
Study of Alagebrium in Patients With Insulin-Dependent Type 1 Diabetes and Microalbuminuria treatment 2 terminated NCT01796418
Beraprost Sodium and Arterial Stiffness in Patients With Type 2 Diabetic Nephropathy treatment Not Available unknown_status NCT00240019
Maximizing the Benefit of Renin-Angiotensin Blocking Drugs in Diabetic Renal Disease. treatment Not Available completed NCT01875341
Role of Sleep Apnea and Sympathetic Activity in Resistant Hypertensive Patients. No drug interventions treatment 3 completed NCT02040441
Proteomic Prediction and Renin Angiotensin Aldosterone System Inhibition Prevention Of Early Diabetic nephRopathy In TYpe 2 Diabetic Patients With Normoalbuminuria diagnostic 2 / 3 completed NCT01068041
Effects of PH3 in Diabetic Nephropathy No drug interventions prevention 2 completed NCT01307917
Flavonoids in the Treatment of Endothelial Dysfunction in Children With Diabetes No drug interventions prevention Not Available withdrawn NCT01802034
Repository of Novel Analytes Leading to Autoimmune, Inflammatory and Diabetic Nephropathies (RENAL AID) No drug interventions Not Available Not Available recruiting NCT00544934
Multiple Dose Trial of Anti-glycation Agent GLY-230 in Healthy and Diabetic Subjects No drug interventions treatment 1 / 2 completed NCT01703234
FGF-23 and Endothelial Dysfunction in Diabetic Proteinuric Patients treatment 4 completed NCT00914524
Study of Olmesartan Medoxomil (CS-866) in Patients With Chronic Glomerulonephritis or Diabetic Nephropathy treatment 2 completed NCT01756716
A Study to Evaluate Pharmacodynamics, Safety, Tolerability and Pharmacokinetics of MT-3995 in Type II Diabetic Nephropathy Subjects With Albuminuria and Moderately Decreased GFR treatment 2 completed NCT00315016
Eplerenone, ACE Inhibition and Albuminuria treatment 2 completed NCT00296296
Immunosuppression Impact on the Metabolic Control of Kidney Transplant With Pre-Existing Type 2 Diabetes (DM) treatment 4 completed NCT01810822
Sex-specific Association With Kidney Disease No drug interventions Not Available Not Available completed NCT04562025
Clinical Research of UC-MSCs in the Treatment of Diabetic Nephropathy treatment Not Available unknown_status NCT00893425
Effect of Renin Angiotensin System Blockade on the Fas Antigen (CD95) and Asymmetric Dimethylarginine (ADMA) Levels in Type-2 Diabetic Patients With Proteinuria treatment 4 completed NCT04027530
Renal Oxygenation, Oxygen Consumption and Hemodynamic Kinetics in Type 2 DIabetes: an Ertugliflozin Study. prevention 4 completed NCT01129557
Aldosterone Breakthrough During Diovan, Tekturna, and Combination Therapy in Patients With Proteinuric Kidney Disease treatment 4 terminated NCT00497666
Association Between Rosiglitazone Use and Clinical Course of Diabetic Nephropathy: Population-Based Study No drug interventions Not Available Not Available unknown_status NCT00004266
Drugs for High Blood Pressure and High Cholesterol in American Indians With Type 2 Diabetes prevention 3 completed NCT00556465
Efficacy of N-Acetylcysteine in Treatment of Overt Diabetic Nephropathy treatment 2 / 3 completed NCT02517320
Efficacy and Safety of MT-3995 in Patients With Diabetic Nephropathy treatment 2 completed NCT01130727
The Effect of Green Tea or Cocoa Extracts in Endothelial Dysfunction in Patients With Diabetes Mellitus No drug interventions treatment Not Available completed NCT00118976
Maximal Dose of Angiotensin Converting Enzyme (ACE) Inhibitor for Treatment of Diabetic Kidney Disease prevention Not Available completed NCT00362960
Olmesartan Medoxomil and Diabetic Nephropathy treatment 3 completed NCT02704494
Resveratrol's Effects in Diabetic Nephropathy treatment 0 completed NCT02914691
Effects of Dapagliflozin Treatment on Urinary Proteomic Patterns in Patients With Type 2 Diabetes No drug interventions prevention 4 completed NCT00518362
To Compare the Efficacy and Safety of Tripterygium (TW) Versus Valsartan in the Diabetic Nephropathy (DN) No drug interventions treatment Not Available completed NCT00312780
Study of XL784 in Patients With Albuminuria Due to Diabetic Nephropathy treatment 2 completed NCT00967629
Effect of Sevelamer Carbonate on Oxidative Stress in Patients With Diabetic Nephropathy treatment 1 completed NCT01779089
Minocycline and Proteinuria in Diabetic Nephropathy treatment Not Available unknown_status NCT06095544
Enhanced Recovery After Surgery for SPK Transplantation Recipients No drug interventions health_services_research Not Available completed NCT02251067
Phase 2 Study to Evaluate Safety & Efficacy of VPI-2690B in Diabetic Nephropathy Patients No drug interventions treatment 2 completed NCT01935167
To Determine the Efficacy and Safety of DW1029M on Microalbuminuria in Patients With Diabetic Nephropathy No drug interventions treatment 2 completed NCT01113801
A Study in Participants With Diabetic Kidney Disease No drug interventions treatment 2 terminated NCT02676401
An Extended Treatment Study of MT-3995 in Patients With Diabetic Nephropathy treatment 2 completed NCT01476501
Vitamin D Supplementation in Diabetic Nephropathy treatment 2 completed NCT02205372
Safety, Tolerability and Pharmacokinetic Study of MT-3995 at a Low Dose in Subjects With Diabetic Nephropathy treatment 1 / 2 completed NCT00222846
Enhancing Adherence in Type 2 Diabetes: The ENHANCE Study No drug interventions Not Available Not Available completed NCT01109212
The Effects of Bindarit in Diabetic Nephropathy treatment 2 completed NCT00130312
Effect of Sulodexide in Overt Diabetic Nephropathy treatment 4 terminated NCT01725412
Prevention of Renal Complications of Diabetes With Thiamine No drug interventions treatment 4 unknown_status NCT01869881
Effect of Sarpogrelate On the Nephropathy in Type 2 Diabetes (SONATA Study) treatment 4 completed NCT01774981
Study of LY3016859 in Participants With Diabetic Nephropathy treatment 1 / 2 completed NCT01667614
Effects of Spironolactone Combination Therapy on Proteinuria, Kidney Function, and Blood Pressure treatment 2 completed NCT01743014
Ramipril and Clopidogrel in Oxidative Stress, Vascular Inflammation and Endothelial Dysfunction in Type 2 Diabetes and Diabetic Nephropathy treatment 4 unknown_status NCT01371955
Impact of c242T Polymorphism of p22phox in Diabetic type1 Nephropathy No drug interventions Not Available Not Available completed NCT00097955
Safety and Efficacy of Aliskiren When Added to Standardized Losartan and Optimal Antihypertensive Therapy in Patients With Hypertension, Type 2 Diabetes and Proteinuria other 2 completed NCT01493050
The Effects of Sevelamer Carbonate on Diabetic Nephropathy treatment 2 completed NCT00130208
Effect of Sulodexide in Early Diabetic Nephropathy treatment 3 completed NCT00754143
Phase 1 Study of FG-3019 in Subjects With Type 1 or Type 2 Diabetes Mellitus and Diabetic Nephropathy treatment 1 completed NCT01756703
A Study to Evaluate Pharmacodynamics, Safety, Tolerability and Pharmacokinetics of MT-3995 in Type II Diabetic Nephropathy Subjects With Albuminuria treatment 2 completed NCT05330390
Study on the Population Pharmacokinetics of Levetiracetam in Epileptic Patients With Diabetic Kidney Disease Not Available Not Available unknown_status NCT01328821
Safety, Tolerability, and Pharmacokinetics (PK) of CTP-499 treatment 1 completed NCT00870402
Aldosterone in Diabetic Nephropathy treatment 4 unknown_status NCT00462202
Open Label Tolerability and Safety Study of KRX-101 in Australia, New Zealand, and Hong Kong treatment 3 terminated NCT05797051
Application of Hyperspectral Imaging in the Diagnosis of Glomerular Diseases No drug interventions Not Available Not Available not_yet_recruiting NCT04750577
A Study to Test the Effect of Different Doses of BI 685509 on Kidney Function in People With Diabetic Kidney Disease treatment 2 completed NCT06431477
Efficacy and Safety of Telmisartan Compared With Losartan treatment 4 recruiting NCT01320345
The Fenofibrate And Microvascular Events in Type 1 Diabetes Eye. treatment 3 recruiting NCT02690883
Effect of Exenatide on 24h-UAER in Patients With Diabetic Nephropathy prevention 4 completed NCT03899883
Uric Acid Lowering Trial in Youth Onset T2D treatment 2 recruiting NCT04869761
Stem Cell Therapy for Chronic Kidney Disease No drug interventions other 1 active_not_recruiting NCT02515461
Low Energy Shockwave Therapy (LE-SWT): A Novel Treatment for Chronic Kidney Disease No drug interventions treatment Not Available unknown_status NCT02017171
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes prevention 3 completed NCT00136188
Nitric Oxide (NO) Activity and Diabetic Nephropathy treatment 2 / 3 completed NCT00153088
INNOVATION Study - Telmisartan (Micardis) in Incipient Diabetic Nephropathy treatment 4 completed NCT03933956
Metabolic Effects of the SGLT-2 Inhibitor Empagliflozin in Patients With Diabetic Nephropathy (MEDiaN) basic_science 3 terminated NCT06147232
Prevention of Chronic Kidney Disease(CDK) Progression in Type 1 Diabetes With Long Term Use of Sodium-Glucose-coTransporter Inhibitors Avoiding Kidney hypOxia treatment 4 not_yet_recruiting NCT04916132
Diabetic Nephropathy in People With Diabetes. Prevalence and Predictive Factors No drug interventions Not Available Not Available recruiting NCT03006952
Add-on Pentoxifylline to Losartan Versus Increasing Dose of Losartan on NT-PRO BNP in Type 2 Diabetics With Nephropathy prevention 4 completed NCT00915200
N-Acetylcysteine and Milk Thistle for Treatment of Diabetic Nephropathy No drug interventions treatment 2 completed NCT00446459
Effects of Mycophenolate Mofetil (MMF) On Anti-HLA (Human Leukocyte Antigen)Antibody Levels In Patients Awaiting Cadaveric Renal Transplant. treatment 2 completed NCT00306436
Comprehensive Management of Diabetic Patients With Renal Impairment : Impact on Blood Pressure and Glycemic Control No drug interventions Not Available Not Available unknown_status NCT03889236
Dietary Interventions on Glycocalyx Dimensions in South Asian Patients With Diabetic Nephropathy. No drug interventions treatment Not Available completed NCT03334318
PERL Continuous Glucose Monitoring (CGM) Study Not Available Not Available completed NCT05840796
To Explore the Anti-oxidative Effects and Inflammation Effects of Soy Protein to Renal Function of End Stage Diabetes Nephropathy Patients No drug interventions treatment Not Available completed NCT03284996
Doppler Ultrasound in Early Detection of Diabetic Nephropathy Type 2 Diabetes Mellitus. No drug interventions Not Available Not Available unknown_status NCT03535935
Efficacy, Safety and Response Predictors of Adjuvant Astragalus Therapy for Diabetic Kidney Disease No drug interventions treatment 2 / 3 unknown_status NCT06466135
Study of WAL0921 in Patients With Glomerular Kidney Diseases No drug interventions treatment 2 recruiting NCT05656963
The Influencing Factors and Mechanism of High Incidence of Thrombotic Events in Patients With MN and DKD No drug interventions Not Available Not Available active_not_recruiting NCT04084886
TCF7L2 Gene Polymorphism and AGEs in Diabetic Nephropathy No drug interventions Not Available Not Available unknown_status NCT03325322
Inflammation and Stem Cells in Diabetic and Chronic Kidney Disease No drug interventions treatment 2 suspended NCT00737126
The Effect of Folic Acid Administration in the Progression of Microalbuminuria treatment Not Available completed NCT00448526
Effect of Low Protein Diet in Preventing the Progression of Diabetic Nephropathy No drug interventions prevention Not Available terminated NCT05974566
Efficacy and Safety of Finerenone in Heart Failure With Reduced Ejection Fraction No drug interventions Not Available Not Available not_yet_recruiting NCT03618420
Copeptin in Adolescent Participants With Type 1 Diabetes and Early Renal Hemodynamic Function diagnostic 1 / 2 completed NCT03620773
Impact of Metabolic Surgery on Pancreatic, Renal and Cardiovascular Health in Youth With Type 2 Diabetes diagnostic 1 / 2 active_not_recruiting NCT03165227
This Study Tests a New Medicine Called BI 685509 in Patients That Have Kidney Problems Because of Diabetes. The Study Tests How BI 685509 is Taken up in the Body and How Well it is Tolerated (Multiple Rising Doses) No drug interventions treatment 1 completed NCT05147194
The Effects of TMZ on Diabetic Nephropathy treatment 2 unknown_status NCT01200394
A Phase 2, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of PF-00489791 In Patients With Type 2 Diabetes And Overt Nephropathy treatment 2 completed NCT03690180
Hypomagnesemia and Diabetic Nephropathy No drug interventions Not Available Not Available completed NCT05282680
The Hong Kong Diabetes Biobank No drug interventions Not Available Not Available recruiting NCT06031389
Henagliflozin Delays the Progress of Diabetic Nephropathy Via Regulates Gut-Renal Axis basic_science Not Available not_yet_recruiting NCT03165240
This International Study Tests BI 690517 in Patients With Diabetic Kidney Disease. The Study Tests How 3 Different Doses of BI 690517 Are Taken up in the Body and How Well They Are Tolerated treatment 1 completed NCT02145572
Metabolomic Profiling in Adolescents With Obesity and Diabetes No drug interventions Not Available Not Available completed NCT01968668
Safety and Efficacy of Different Oral Doses of BAY94-8862 in Japanese Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Nephropathy (ARTS-DN Japan) treatment 2 completed NCT04074668
Control of Renal Oxygen Consumption, Mitochondrial Dysfunction, and Insulin Resistance Not Available Not Available completed NCT03840343
Patient-Derived Stem Cell Therapy for Diabetic Kidney Disease No drug interventions treatment 1 terminated NCT05319990
Pathogenesis of Kidney Disease in Type 1 Diabetes: a Modern Kidney Biopsy Cohort (The PANDA Study) Not Available Not Available recruiting NCT03216564
An Intervention to Examine the Effect of Vitamin D on Urine Protein Levels in Type 2 Diabetes treatment 3 unknown_status NCT04235621
A Study to Understand the Genetics and Clinical Course of Focal Segmental Glomerulosclerosis (FSGS), Treatment-Resistant Minimal Change Disease (TR-MCD), and Diabetic Nephropathy (DN) No drug interventions Not Available Not Available terminated NCT02442921
Colchicine for Diabetic Nephropathy Trial treatment 1 / 2 unknown_status NCT03573102
Effect of Sodium Glucose co Transporter 2 Inhibitor ( SGLT2) on Proteinuria in Diabetic Patients treatment 4 unknown_status NCT04029402
Molecular Analysis of Diabetic Kidney Disease Biopsies No drug interventions Not Available Not Available recruiting NCT02986984
Transformative Research in Diabetic Nephropathy No drug interventions Not Available Not Available recruiting NCT04929379
A Pilot Study of Fenofibrate to Prevent Kidney Function Loss in Type 1 Diabetes treatment 2 recruiting NCT03509454
PeRsOnalising Treatment Of Diabetic Nephropathy: No drug interventions Not Available Not Available completed NCT00446251
Effects of Rituximab and Mycophenolate Mofetil (MMF) on Highly Sensitized Patients Awaiting Renal Transplant treatment 2 completed NCT03878277
Evaluation of Coffee Therapy for Improvement of Renal Oxygenation No drug interventions treatment 2 completed NCT02552277
A Efficacy and Safety Study of Intramuscular Injection of Human Placenta-Derived Cells (PDA-002) in Subjects With Diabetic Peripheral Neuropathy No drug interventions treatment 2 completed NCT03945747
MEtabolic and Renal Effects of AutoMAted Insulin Delivery Systems in Youth With Type 1 Diabetes Mellitus No drug interventions Not Available Not Available active_not_recruiting NCT02410005
Intervention Using Vitamin D for Elevated Urinary Albumin Treated With Losartan in Diabetes (IDEAL) treatment 2 / 3 terminated NCT00713011
Adalat XL vs Diltiazem on Proteinuria and Blood Pressure in Hypertensive Diabetic Patients treatment 3 withdrawn NCT03288571
Use of Wharton Jelly in Diabetic Nephropathy No drug interventions treatment 1 / 2 unknown_status NCT01918488
Increased Activity of a Renal Salt Transporter (ENaC) in Diabetic Kidney Disease basic_science Not Available unknown_status NCT05530356
Renal Hemodynamics, Energetics and Insulin Resistance: A Follow-up Study Not Available Not Available enrolling_by_invitation NCT02001532
Arterial Stiffness and Complication Risk in Type 2 Diabetes No drug interventions Not Available Not Available completed NCT02488252
Semi-individualised Chinese Medicine Treatment as an Adjuvant Management for Diabetic Nephropathy No drug interventions treatment 2 / 3 unknown_status NCT00237952
Environmental Exposure to Lead and Progressive Renal Insufficiency in Type II Diabetic Nephropathy No drug interventions treatment Not Available completed NCT05718375
Phase IIb Clinical Trial for the Efficacy and Safety by CU01-1001 for 24 Weeks in Type 2 DM Patients With Albuminuria No drug interventions treatment 2 recruiting NCT05357742
Basic Needs Navigation Intervention to Address Multidimensional Adversity in African Americans With Diabetic Kidney Disease No drug interventions health_services_research Not Available recruiting NCT04705506
Gemigliptin and Biomarkers of Kidney Injury and Vascular Calcification treatment Not Available completed NCT03201406
Retrospective Analysis of Renal Prognosis in Patients With Chronic Kidney Disease No drug interventions Not Available Not Available unknown_status NCT03137316
Prevalence of Secondary Hyperparathyroidism Among Patients With Diabetic Nephropathy No drug interventions Not Available Not Available completed NCT03921216
Cholesterol Metabolism in Plasma and Interstitial Fluid Among Subjects Undergoing Hemodialysis. No drug interventions Not Available Not Available suspended NCT03820635
Markers of Vascular Calcification in Diabetic Nephropathy in Patients With Diabetic Nephropathy No drug interventions Not Available Not Available unknown_status NCT04570735
MRI Biomarkers in Diabetic Kidney Disease No drug interventions Not Available Not Available unknown_status NCT02682563
Renoprotective Effects of Dapagliflozin in Type 2 Diabetes prevention 4 completed NCT04531163
Possible Ameliorating Effect of N- Acetylcysteine (NAC) on Type-II Diabetes Induced Nephropathy treatment 2 / 3 unknown_status NCT04799925
Hyperuricemia and Diabetic Nephropathy Not Available Not Available unknown_status NCT04317430
Niclosamide Role in Diabetic Nephropathy treatment 3 completed NCT04387448
A Study of TRPC5 Channel Inhibitor in Patients With Diabetic Nephropathy, Focal Segmental Glomerulosclerosis, and Treatment-Resistant Minimal Change Disease No drug interventions treatment 2 terminated NCT00168857
A Prospective, Randomised, Double-blind, Double-dummy, Forced-titration, Multicentre, Parallel Group, One Year Treatment Trial to Compare Telmisartan (MICARDIS) 80 mg Versus Losartan (COZAAR) 100 mg, in Hypertensive Type 2 Diabetic Patients With Overt Nephropathy (AMADEO Study) treatment 4 completed NCT05418465
Huangqi Guizhi Wuwu Decoction in CKD Stage 2-4 Diabetic Nephropathy treatment Not Available unknown_status NCT03869931
Effects of Fenofibrate Therapy in Diabetic Nephropathy treatment 3 unknown_status NCT01874431
Safety and Efficacy of Different Oral Doses of BAY94-8862 in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Nephropathy treatment 2 completed NCT02299960
Measurement of Endothelial Function and Cardiac Output: New Methods No drug interventions Not Available Not Available completed NCT06563791
Assessment of the Association Between Visceral Obesity and the Progression of Diabetic Nephropathy No drug interventions Not Available Not Available not_yet_recruiting NCT04880291
First-In-Human Study of GFB-024 in Healthy Overweight and Obese Participants, and Participants With Type 2 Diabetes No drug interventions treatment 1 completed NCT06441591
Clinical Outcome of Vinpocetine in Diabetic Nephropathy treatment 2 / 3 recruiting NCT03885362
Assessment of the Accuracy of Continuous Glucose Sensors in People With Diabetes Undergoing Haemodialysis No drug interventions prevention Not Available completed NCT05638880
Clinical Study to Evaluate the Possible Efficacy and Safety of Levocetirizine in Patients With Diabetic Kidney Disease treatment 2 recruiting NCT04119167
Use of GDF15 as a Biomarker for Early Diagnosis of DM and Monitoring of Progress of Complications in Asians No drug interventions Not Available Not Available unknown_status NCT01094769
Sympathetic Nervous System Inhibition for the Treatment of Diabetic Kidney Disease treatment 4 completed NCT04755946
Possible Role of Roflumilast in Diabetic Nephropathy treatment 3 unknown_status NCT04988581
Prevention In Community Clinics From Diabetic Kidney Disease No drug interventions prevention Not Available not_yet_recruiting NCT03212755
Serum Immunoglobulin (G) as a Marker of Diabetic Nephropathy No drug interventions screening Not Available unknown_status NCT00153023
1 Year Trial Telmisartan 80 mg Versus Valsartan 160 mg in Hypertensive Type 2 Diabetic Patients With Overt Nephropathy treatment 4 completed NCT00438503
Glucose in Dialysis Water in Diabetics With Chronic Renal Failure No drug interventions treatment 4 completed NCT06224790
Perfenidone in Type 2 Diabetic Patients With Diabetic Neuropathy treatment 4 recruiting NCT06217302
Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease prevention 3 not_yet_recruiting NCT04380584
Relation Between Plasma Apelin Level and Diabetic Nephropathy in Type 2 Diabetes Patients. No drug interventions Not Available Not Available completed NCT03824379
Magnesium Supplementation in Diabetic Nephropathy No drug interventions treatment 2 completed NCT01575379
A Pilot Study of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes prevention 4 terminated